Polymerase Chain Reaction Molecular Diagnostics Growth Trajectory: Key Forecasts and Strategic Insights
We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Fast Is The Polymerase Chain Reaction Molecular Diagnostics Market Expected to Grow Between 2025 And 2029?
Over the past few years, the polymerase chain reaction molecular diagnostics market has been demonstrating immense growth. It is projected to escalate from $8.97 billion in 2024 to $9.78 billion in 2025, representing a compound annual growth rate (CAGR) of 9.0%. This robust growth during the historical period can be attributed to factors such as the rising demand for early disease detection, increased incidence of infectious diseases, greater awareness regarding genetic disorders, a growing preference for point-of-care testing, and a notable rise in chronic diseases.
The market size for polymerase chain reaction molecular diagnostics is predicted to experience robust growth in the upcoming years, reaching a projected $13.64 billion in 2029 with a compound annual growth rate (CAGR) of 8.7%. This growth throughout the forecast period can be linked to various factors including an increase in cancer cases, growing preference for personalized medicine, heightened investment in molecular diagnostics, a surge in demand for quick diagnostic tests, and a rise in demand for non-invasive prenatal tests. Key trends expected for the forecast period are improvements in diagnostic technologies, creation of point-of-care polymerase chain reaction systems, innovations in multiplex polymerase chain reaction, consolidation of polymerase chain reaction with microfluidics, and technological enhancements in digital polymerase chain reaction platforms.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp
Which Factors and External Forces Are Driving Demand in the Polymerase Chain Reaction Molecular Diagnostics Market?
As infectious diseases become more prevalent, they are anticipated to fuel the upward trajectory of the polymerase chain reaction molecular diagnostics market. Infectious diseases are caused by damaging microorganisms including bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between individuals. Increasing incidences of these diseases can be attributed to the rise of antibiotic-resistant pathogens that are more difficult to treat and manage, resulting in extended illnesses, increased healthcare expenditures, and heightened risks to public health. Polymerase chain reaction (PCR) molecular diagnostics improves the management of infectious diseases by enabling swift and exact detection of pathogens at the genetic level. This allows for early diagnosis and precise treatments, leading to better healthcare outcomes by enabling timely interventions, slowing the spread of infections, and enhancing patient care. As an example, in November 2023, the Department of Health and Human Services, a US government department, revealed that the number of newly diagnosed chronic hepatitis B (a viral infection that impacts the liver, potentially causing acute and chronic disease) cases in 2022 saw an increase of 11% compared to the previous year. Consequently, the escalating prevalence of infectious diseases is a major factor contributing to the growth of the polymerase chain reaction molecular diagnostics market.
Which Segments in the Polymerase Chain Reaction Molecular Diagnostics Offer the Most Growth?
The polymerase chain reaction molecular diagnostics market covered in this report is segmented –
1) By Product Type: Instrument, Reagents And Consumables, Software
2) By Technology: Real-Time Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Conventional Polymerase Chain Reaction
3) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Urine Samples
4) By Application: Infectious Disease Testing, Oncology Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Instrument: Standard Polymerase Chain Reaction Systems, Digital Polymerase Chain Reaction Systems, Real-Time Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Polymerase Chain Reaction Kits, Polymerase Chain Reaction Enzymes, Polymerase Chain Reaction Primers and Probes, Polymerase Chain Reaction Master Mix
3) By Software: Polymerase Chain Reaction Analysis Software, Data Management Software
Request customized data on this market:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp
What Are the Fastest-Growing Geographies in the Polymerase Chain Reaction Molecular Diagnostics Market?
North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive the Polymerase Chain Reaction Molecular Diagnostics Market’s Growth?
Leading businesses in the polymerase chain reaction molecular diagnostics marketplace are putting their efforts towards producing technologically innovative solutions like benchtop instruments, in order to improve the effectiveness and accessibility of testing. The term ‘benchtop instruments’ denotes compact, laboratory-grade gadgets that can comfortably fit on a table or workbench and are employed for scientific, medical, or industry-related testing and analysation. For instance, the QIAcuityDx Digital PCR System, a product of the Germany-based biotech firm QIAGEN N.V., was introduced to the market in September 2024 for oncology-based clinical testing. The salient features of this system are its full automation and walk-away processing – measures that bring together partitioning, thermocycling, and imaging into one instrument, offering precise quantification of deoxyribonucleic acid and ribonucleic acid with outcomes delivered in approximately two hours and minimal hand-on time. The said system supports up to five detection channels for multiplexing, and continuous nanoplate loading – all the while offering both validated and flexible research modes, making it a versatile choice for various clinical and laboratory applications.
View the full report here:
What Are the Key Elements That Define the Polymerase Chain Reaction Molecular Diagnostics Market?
Polymerase chain reaction (PCR) molecular diagnostics is a laboratory technique used to amplify and analyze specific deoxyribonucleic acid or ribonucleic acid sequences in a sample. Its main purpose is to detect the presence of specific genetic material, enabling the identification of pathogens, genetic disorders, or mutations. It is widely used in medical diagnostics for detecting infectious diseases, genetic disorders, and cancer markers with high sensitivity and accuracy.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
